Stockreport

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approximately $105 million in h [Read more]